Michael Ermanediting News Today

Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to...

-Around 1.8 million people in the U.S. received a COVID-19 vaccine during the week ended Sept. 22, according to data compiled by health care data and analytics firm IQVIA Holdings Inc.... -September 29, 2023 at 03:57 pm EDT - MarketScreener

By Michael Erman (Reuters) -Around 1.8 million people in the U.S. received a COVID-19 vaccine during the week ended Sept. 22, according to data compiled by ...

(Reuters) -Merck & Co posted better-than-expected second-quarter sales on Tuesday on strong demand for its two top-selling products, cancer immunotherapy Keytruda and human papillomavirus (HPV) vaccine Gardasil. Shares of Merck rose about 2% at $108.45 in premarket trading after the company also raised its full-year revenue forecast. Merck said Keytruda sales for the quarter jumped 19% to $6.3 billion, surpassing analysts' average estimate of $5.9 billion.

By Michael Erman (Reuters) -Swiss drugmaker Roche Holding AG plans to sell its 800-employee drug manufacturing plant in Vacaville, California, or it will ...

By Michael Erman NEW YORK (Reuters) -COVID-19 vaccine maker Novavax Inc on Tuesday raised doubts about its ability to remain in business and announced...

COVID-19 vaccine maker Novavax Inc on Tuesday raised doubts about its ability to remain in business and announced plans to slash spending as it works to prepare for a fall vaccination campaign.

NEW YORK, Sept 22 (Reuters) - The United States is significantly cutting back the number of Pfizer PFE.N/BioNTech 22UAy.DE Covid-19 vaccine doses it will buy for donation to poorer nations this year, Pfizer said on Thursday, citing diminished demand for the shots in those countries.

Coronavirus vaccines tweaked to include the Omicron variant strain can improve protection when used as a booster, the European Medicines Agency and other global health regulators said.

(Corrects first name of CDC researcher in fourth paragraph)